Lantern Pharma Inc. Earnings Per Share Diluted

Quick Answer

Lantern Pharma Inc. reported Earnings Per Share Diluted of $1.57 (loss) per share for the year ending 2025.

  • Lantern Pharma Inc. showed an increase of +18.7% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Lantern Pharma Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), Lantern Pharma Inc.'s Earnings Per Share Diluted has declined by 19.8%.
  • Historical annual values: Fiscal year 2025: $1.57 (loss) per share | Fiscal year 2024: $1.93 (loss) per share | Fiscal year 2023: $1.47 (loss) per share | Fiscal year 2022: $1.31 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: